Table 2.
Formulations, and mean ± standard deviation (each n = 50) nodule and pore sizes for monoliths consisting of 1% DMPA initiator in a mixture of OMA, EDMA, 1-dodecanol, and cyclohexanol. Formulations also correspond to panel letters in Figure 2. Formulations A-F maintained a 1:1 OMA:EDMA ratio while varying the OMA+EDMA:porogen ratio. Formulations G-L maintained a 65% total porogen content while varying the OMA:EDMA ratio.
| Monolith Formulation | OMA (%) | EDMA (%) | 1-Dodecanol (%) | Cyclohexanol (%) | Average Nodule Size (μm) | Average Pore Size (μm) |
|---|---|---|---|---|---|---|
| A | 20 | 20 | 50 | 10 | 0.14 ± 0.04 | 0.21 ± 0.09 |
| B | 20 | 20 | 60 | 0.89 ± 0.19 | 0.98 ± 0.58 | |
| C | 17.5 | 17.5 | 55 | 10 | 0.91 ± 0.56 | 1.21 ± 0.34 |
| D | 17.5 | 17.5 | 65 | 1.51 ± 0.39 | 2.19 ± 1.36 | |
| E | 15 | 15 | 60 | 10 | 1.48 ± 0.35 | 2.55 ± 1.04 |
| F | 15 | 15 | 70 | 0.41 ± 0.08 | 0.58 ± 0.24 | |
| G | 20 | 15 | 55 | 10 | n/a | n/a |
| H | 20 | 15 | 65 | 0.32 ± 0.05 | 0.33 ± 0.17 | |
| I | 15 | 20 | 55 | 10 | 0.45 ± 0.07 | 0.67 ± 0.21 |
| J | 15 | 20 | 65 | 0.85 ± 0.13 | 1.51 ± 0.73 | |
| K | 10 | 25 | 55 | 10 | 1.25 ± 0.18 | 1.87 ± 0.80 |
| L | 10 | 25 | 65 | 0.93 ± 0.25 | 1.50 ± 0.88 |